LRFN1 Activators are a diverse array of chemical compounds that each contribute to the functional enhancement of LRFN1 through various cellular signaling mechanisms. For instance, Phorbol 12-myristate 13-acetate (PMA) is known to robustly activate protein kinase C (PKC), leading to the phosphorylation of substrates that can enhance the synaptic function of LRFN1. Similarly, Forskolin, by increasing intracellular cAMP levels, indirectly augments the functional activity of LRFN1 by activating protein kinase A (PKA), which in turn phosphorylates proteins that modulate the synaptic localization of LRFN1. The cAMP analogs, 8-Bromo-cAMP and Dibutyryl-cAMP, also act through PKA activation, leading to a potentiation of LRFN1's role in synaptic modulation. Isoproterenol and Nicotine both drive synaptic plasticity processes that can enhance LRFN1 function, with Isoproterenol increasing cAMP and Nicotine activatingnicotinic receptors that modulate synaptic plasticity and LRFN1 activity. N6-Cyclopentyladenosine (CPA) activates adenosine A1 receptors, affecting cAMP signaling and thus potentially promoting LRFN1's synaptic efficacy.
Ionomycin and Calcium chloride, through their capacity to elevate intracellular calcium levels, indirectly foster the activity of LRFN1 by activating calcium-dependent protein kinases that phosphorylate proteins interacting with LRFN1, enhancing its role at neuronal synapses. Conversely, Lithium chloride's inhibition of GSK3 may stabilize synaptic proteins, indirectly leading to an increase in LRFN1 synaptic function. Bisindolylmaleimide I (BIM), although a PKC inhibitor, may indirectly enhance LRFN1 activity by modulating specific PKC isoforms that have nuanced effects on synaptic signaling pathways. The direct activation of NMDA receptors by NMDA itself can impact neuroplasticity and signaling pathways that upregulate the incorporation of LRFN1 into synaptic complexes, thereby enhancing its function. Collectively, these LRFN1 Activators, through their targeted influence on signaling pathways and cellular processes, serve to potentiate the action of LRFN1 in the nervous system, specifically at synapses where it plays a critical role in modulating neuronal communication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC) which can phosphorylate multiple substrates, including proteins that interact with LRFN1. Through PKC activation, intracellular signaling pathways that influence the synaptic localization and function of LRFN1 are enhanced. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
As a cell-permeable cAMP analog, 8-Bromo-cAMP can activate PKA. PKA can then phosphorylate proteins associated with LRFN1, enhancing its synaptic function. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a stable cAMP analog that activates PKA. PKA phosphorylates targets that can interact with LRFN1, thereby promoting its activity in synaptic modulation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, potentially affecting calcium-dependent protein kinases which can phosphorylate proteins associated with LRFN1 and enhance its activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase 3 (GSK3). GSK3 inhibition can lead to the stabilization and increased functional activity of proteins, potentially enhancing the synaptic function of LRFN1. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
BIM is a selective PKC inhibitor. However, by inhibiting specific PKC isoforms, it may paradoxically enhance signaling pathways that upregulate the activity of LRFN1, due to the complex regulation of PKC on synaptic proteins. | ||||||
N-Methyl-D-Aspartic acid (NMDA) | 6384-92-5 | sc-200458 sc-200458A | 50 mg 250 mg | $109.00 $369.00 | 2 | |
N-Methyl-D-aspartate (NMDA) receptor agonists like NMDA can modulate synaptic plasticity. Activation of NMDA receptors can influence signaling pathways that promote the incorporation and function of LRFN1 in synapses. | ||||||
Calcium chloride anhydrous | 10043-52-4 | sc-207392 sc-207392A | 100 g 500 g | $66.00 $262.00 | 1 | |
Calcium chloride can increase intracellular calcium levels, which may activate calcium-dependent protein kinases. These kinases can phosphorylate synaptic proteins and enhance the synaptic activity of LRFN1. | ||||||